UNIVERSITY BEHAVIORAL HEALTHCARE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $798K
- Transactions
- 125
- Companies
- 17
- Average per transaction
- $6,381
Who reported the payments
| Takeda Pharmaceuticals U.S.A., Inc. | $306,845 |
| AbbVie | $138,346 |
| Jenavalve Technology, Inc. | $82,363 |
| BTG International Inc. | $60,060 |
| Straumann USA LLC | $49,190 |
| Genentech, Inc. | $34,590 |
| Karyopharm Therapeutics Inc. | $27,472 |
| Varian Medical Systems, Inc. | $25,000 |
| Medline Industries LP | $25,000 |
| Indivior Inc. | $17,769 |
| Novartis | $12,345 |
| Merit Medical Systems Inc | $11,814 |
| Heron Therapeutics, Inc. | $2,060 |
| Dermira, Inc. | $2,000 |
| Olympus America Inc. | $1,093 |
| Bio-rad Laboratories, Inc. | $1,044 |
| Welch Allyn | $624 |